Upload
Featured Recent Articles Topics Login Upload

Search Results for 'patients myeloma'

patients myeloma published presentations and documents on DocSlides.

Myeloma hope
Myeloma hope
by sherrill-nordquist
new treatment in the horizon. Dr Amin . I. slam ....
Mait Raava Estonian Myeloma Society
Mait Raava Estonian Myeloma Society
by tawny-fly
Copenhagen. , . June 11. th. . 2016. EU Drug App...
How to Manage High Risk Myeloma
How to Manage High Risk Myeloma
by tatiana-dople
Dr Matthew Jenner. Consultant Haematologist. Sout...
The place of newer imaging techniques in multiple myeloma
The place of newer imaging techniques in multiple myeloma
by alexa-scheidler
Dr. Andrew Chantry. Senior Clinical Lecturer and...
meeting summary Autumn 2021 MEETINGS in Multiple Myeloma
meeting summary Autumn 2021 MEETINGS in Multiple Myeloma
by cadie
IMW | SOHO | SOHO Italy. Dr.. Claudio . Cerchione...
Multiple myeloma: What’s new?
Multiple myeloma: What’s new?
by sadie
Grace B. Athas, Ph.D. . MLS. Department of patholo...
IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA
IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA
by WatercolorWanderlust
H . Nèji. , H . Abid. , A . Mâalej. , S . Haddar...
Myeloma: Symptoms to diagnosis
Myeloma: Symptoms to diagnosis
by samantha
Can we do better?. [Hospital name]. [Date]. What i...
Multiple Myeloma
Multiple Myeloma
by aaron
NICE Guideline. Published Feb 2016. Adults with m...
Immunotherapy in Multiple Myeloma: where do we go ?
Immunotherapy in Multiple Myeloma: where do we go ?
by kittie-lecroy
Paul Moss. Birmingham, UK. Outline. Introduction ...
Genomic Sequencing in Myeloma:
Genomic Sequencing in Myeloma:
by lindy-dunigan
Ready for Prime Time?. DANA-FARBER . CANCER INSTI...
Diagnosis and Initial Therapy of MM
Diagnosis and Initial Therapy of MM
by tremblay
Myeloma Symposium 9/29/2018. Aric Hall, MD – Ass...
Dr Denis O’Keeffe
Dr Denis O’Keeffe
by trish-goza
Multiple myeloma .The management of the newly dia...
Hans Scheurer President
Hans Scheurer President
by ellena-manuel
. Myeloma. Patients Europe. Disclosure. I have ...
Protein dynamics in early disease
Protein dynamics in early disease
by oneill
Professor Mark Drayson, University of Birmingham. ...
Plasma cell dyscrasia behavior in a referral hospital in southern Colo
Plasma cell dyscrasia behavior in a referral hospital in southern Colo
by bety
Plasma cell dyscrasias are diseases characterized ...
Highlights in Multiple myeloma
Highlights in Multiple myeloma
by amber
How to treat. triple- or penta-refractory . Multip...
MRD in myeloma
MRD in myeloma
by mitsue-stanley
UKMF Spring Day. Assessment of disease response, ...
Relapsed and Refractory Myeloma
Relapsed and Refractory Myeloma
by jane-oiler
Ruben Niesvizky. Myeloma Center. Myelomacenter.or...
Scottsdale, Arizona
Scottsdale, Arizona
by jane-oiler
Rochester, Minnesota. Jacksonville, Florida. Mult...
Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Ltd
by yoshiko-marsland
Study of . clinocopathological. profile and chr...
Central diabetes insipidus
Central diabetes insipidus
by Younggunner
Maryam-kabootari. MD. Research Institute for Endo...
Considerations for Optimizing Transplant in Multiple Myeloma Patient Management
Considerations for Optimizing Transplant in Multiple Myeloma Patient Management
by TravelingSoulmate
PARAMESWARAN HARI MD. MEDICAL COLLEGE OF WISCONSIN...
MGUS and Smoldering Myeloma:
MGUS and Smoldering Myeloma:
by miller
Risk stratification and Therapeutic Options. Natal...
Starr Morning Report Austin Akers, MD Internal Medicine PGY-3
Starr Morning Report Austin Akers, MD Internal Medicine PGY-3
by test
Starr Morning Report Austin Akers, MD Internal Me...
Chronic Leukemia and
Chronic Leukemia and
by ash
Multiple Myeloma . Chronic Leuke...
wvwvyzwvxwyy
wvwvyzwvxwyy
by norah
xFICTION Fluorescence immunophenotyping and inter...
Therapeutic Plasma Exchange:
Therapeutic Plasma Exchange:
by yoshiko-marsland
. indications . in Nephrology. M. Colleen Hastin...
Taylor Butler, PharmD, BCOP
Taylor Butler, PharmD, BCOP
by marina-yarberry
Decentralized Clinical Pharmacist. Department of ...
Pomalidomide
Pomalidomide
by marina-yarberry
therapy in relapsed/refractory myeloma: . A UK m...
Malignant
Malignant
by olivia-moreira
Bone tumors. Malignant vs. Benign Tumors. “. Ra...
Patients with
Patients with
by cheryl-pisano
Back Pain. Dr Nick Pendleton. TIMELINE. About thi...
Genetic plasma cell signatures in high-risk smoldering myel
Genetic plasma cell signatures in high-risk smoldering myel
by trish-goza
Presented By Sham Mailankody at 2016 ASCO Annual ...
Malignant Bone tumors Malignant vs. Benign Tumors
Malignant Bone tumors Malignant vs. Benign Tumors
by myesha-ticknor
“. Rapid growth, warmth, tenderness, and ill de...
Osteoclast Inhibitors in Malignancy
Osteoclast Inhibitors in Malignancy
by onionchevrolet
Joel Brothers. 10/4/2016. Understand the indicatio...
Update on Diagnosis and Treatments
Update on Diagnosis and Treatments
by joanne
of Multiple Myeloma. Kenneth C. Anderson, M.D.. J...
How to Write a Letter of Intent
How to Write a Letter of Intent
by willow
Sarah A. Holstein, MD, PhD. Associate Professor, I...
eloma Toward a New UnderstandingStatement Richard Klausner MD Dire
eloma Toward a New UnderstandingStatement Richard Klausner MD Dire
by pagi
in the marrow to mature or may travel to other par...
MAN DISEASEWhat is Castleman DiseaseCastleman disease CD is a rare
MAN DISEASEWhat is Castleman DiseaseCastleman disease CD is a rare
by sophia
A feeling of fullness or pressure in the chest or ...
Asymptomatic plasma cell dyscrasias –Smoldering myeloma & MGUS
Asymptomatic plasma cell dyscrasias –Smoldering myeloma & MGUS
by yvonne
Aric Hall, MD. Assistant Professor – UW Health. ...